Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Documentation Review Before Report Finalization – V 2.0

Posted on By

Analytical Method Development: SOP for Documentation Review Before Report Finalization – V 2.0

Standard Operating Procedure for Documentation Review Before Finalizing Analytical Reports


Department Analytical Method Development
SOP No. SOP/AMD/393/2025
Supersedes SOP/AMD/393/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP describes the systematic approach to reviewing analytical documentation before finalizing and issuing reports. It ensures accuracy, traceability, data integrity, and compliance with regulatory expectations such as ICH, WHO, and 21 CFR Part 211.

2. Scope

This procedure

applies to all analytical method development (AMD) personnel and QA reviewers involved in the evaluation of analytical data generated during development, validation, or transfer studies.

3. Responsibilities

  • Analyst: Ensures that all data entries, observations, and calculations are complete, legible, and initialed.
  • AMD Reviewer: Conducts comprehensive review of raw data, calculations, chromatograms, and logbook entries.
  • QA Representative: Verifies compliance with data integrity principles, protocol requirements, and SOPs.
See also  Analytical Method Development: SOP for Qualification of Analytical Balances - V 2.0

4. Accountability

The AMD Department Head is accountable for implementing this SOP and ensuring that no analytical report is finalized without documented evidence of prior data review and verification.

5. Procedure

5.1 Preparation for Documentation Review

  1. Ensure that the analytical study is complete and all associated raw data is compiled.
  2. Check inclusion of:
    • Sample preparation records
    • Instrument usage logs
    • System suitability data
    • Chromatograms with peak annotations
    • Calibration curves, calculations, and worksheets

5.2 Data Integrity and Compliance Verification

  1. Verify ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
  2. Cross-check calculations using approved spreadsheet or manual formulas, as applicable.
  3. Confirm that any corrections are GMP-compliant and justified.

5.3 Checklist-Based Review

  1. Use Annexure-1: Pre-Report Review Checklist to confirm the presence and review of each required document and entry.
  2. Note any missing or inconsistent data and return to the originating analyst for clarification or correction.
See also  Analytical Method Development: Determination of Absorptivity Values - V 2.0

5.4 Critical Review Areas

  • Ensure consistent sample identification numbers across all pages
  • Review instrument printouts for alignment with reported results
  • Evaluate chromatograms for baseline noise, peak resolution, retention time matching
  • Ensure dilution factors and standard potency are correctly applied
  • Confirm that specifications and acceptance criteria are referenced and met

5.5 Deviations and OOS/OOT Data Handling

  1. Any Out-of-Specification (OOS) or Out-of-Trend (OOT) result must be reviewed as per SOP/QA/014/2025.
  2. Document such cases using Annexure-2 and attach investigation summary if available.

5.6 Report Finalization and Approval

  1. Upon successful review, sign the documentation review section on the report cover page.
  2. Forward report for QA approval before issuance.
  3. File the completed review checklist with the report (Annexure-1).

6. Abbreviations

  • AMD: Analytical Method Development
  • QA: Quality Assurance
  • OOS: Out-of-Specification
  • OOT: Out-of-Trend
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

  1. Pre-Report Review Checklist – Annexure-1
  2. OOS/OOT Review Log – Annexure-2
See also  Analytical Method Development: SOP for Verification of Analytical Calculations - V 2.0

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • 21 CFR Part 211: cGMP for Finished Pharmaceuticals
  • MHRA GxP Data Integrity Guidance

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Anjali Reddy Rahul Mehta Dr. Harshita Goyal
Designation AMD Analyst QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Pre-Report Review Checklist

Checklist includes: raw data presence, sample ID verification, chromatogram quality, instrument log review, calculation correctness, correction justification, reviewer comments.

Annexure-2: OOS/OOT Review Log

Sample ID Observation Type (OOS/OOT) Action Taken Investigation Ref Status
AMD/VAL/2025/47 Impurity 1 out of limit OOS Investigation initiated INV/AMD/008 Open

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Checklist added, expanded data integrity checks Annual SOP Review Dr. Harshita Goyal
15/08/2022 1.0 Initial Issue New Procedure QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Verification of Analytical Calculations – V 2.0
Next Post: Analytical Method Development: SOP for Issuance and Control of Analytical Raw Data Sheets – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version